Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.

Ruivo E, Adhikari K, Elvas F, Fissers J, Vangestel C, Staelens S, Stroobants S, Van der Veken P, Wyffels L, Augustyns K.

Nucl Med Biol. 2019 Sep - Oct;76-77:36-42. doi: 10.1016/j.nucmedbio.2019.11.001. Epub 2019 Nov 5.

2.

Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [18F]HX4 PET imaging study in colorectal cancer xenografts.

De Bruycker S, Vangestel C, Staelens S, Wyffels L, Detrez J, Verschuuren M, De Vos WH, Pauwels P, Van den Wyngaert T, Stroobants S.

EJNMMI Res. 2019 Aug 2;9(1):74. doi: 10.1186/s13550-019-0543-4.

3.

Bone metastases in the era of targeted treatments: insights from molecular biology.

Dewulf J, Vangestel C, Verhoeven Y, van Dam P, Elvas F, Van den Wyngaert T, Clézardin P.

Q J Nucl Med Mol Imaging. 2019 Jun;63(2):98-111. doi: 10.23736/S1824-4785.19.03203-5. Epub 2019 Jul 11.

PMID:
31298015
4.

First genomic study on Lake Tanganyika sprat Stolothrissa tanganicae: a lack of population structure calls for integrated management of this important fisheries target species.

De Keyzer ELR, De Corte Z, Van Steenberge M, Raeymaekers JAM, Calboli FCF, Kmentová N, N'Sibula Mulimbwa T, Virgilio M, Vangestel C, Mulungula PM, Volckaert FAM, Vanhove MPM.

BMC Evol Biol. 2019 Jan 8;19(1):6. doi: 10.1186/s12862-018-1325-8.

5.

Evolution at two time frames: Polymorphisms from an ancient singular divergence event fuel contemporary parallel evolution.

Van Belleghem SM, Vangestel C, De Wolf K, De Corte Z, Möst M, Rastas P, De Meester L, Hendrickx F.

PLoS Genet. 2018 Nov 13;14(11):e1007796. doi: 10.1371/journal.pgen.1007796. eCollection 2018 Nov.

6.

How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research.

De Bruycker S, Vangestel C, Staelens S, Van den Wyngaert T, Stroobants S.

Contrast Media Mol Imaging. 2018 Oct 18;2018:4608186. doi: 10.1155/2018/4608186. eCollection 2018. Review.

7.

18F-Flortanidazole Hypoxia PET Holds Promise as a Prognostic and Predictive Imaging Biomarker in a Lung Cancer Xenograft Model Treated with Metformin and Radiotherapy.

De Bruycker S, Vangestel C, Van den Wyngaert T, Pauwels P, Wyffels L, Staelens S, Stroobants S.

J Nucl Med. 2019 Jan;60(1):34-40. doi: 10.2967/jnumed.118.212225. Epub 2018 Jul 6.

PMID:
29980581
8.

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.

Jacobs J, Deschoolmeester V, Rolfo C, Zwaenepoel K, Van den Bossche J, Deben C, Silence K, de Haard H, Hermans C, Rottey S, Vangestel C, Lardon F, Smits E, Pauwels P.

Oncotarget. 2017 May 23;8(43):74058-74067. doi: 10.18632/oncotarget.18202. eCollection 2017 Sep 26.

9.

[99mTc]duramycin for cell death imaging: Impact of kit formulation, purification and species difference.

Palmieri L, Elvas F, Vangestel C, Pak K, Gray B, Stroobants S, Staelens S, Wyffels L.

Nucl Med Biol. 2018 Jan;56:1-9. doi: 10.1016/j.nucmedbio.2017.08.005. Epub 2017 Sep 14.

PMID:
29031229
10.

Supplementary feeding increases nestling feather corticosterone early in the breeding season in house sparrows.

Salleh Hudin N, De Neve L, Strubbe D, Fairhurst GD, Vangestel C, Peach WJ, Lens L.

Ecol Evol. 2017 Jun 30;7(16):6163-6171. doi: 10.1002/ece3.3114. eCollection 2017 Aug.

11.

ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice.

Kurdi A, Cleenewerck M, Vangestel C, Lyssens S, Declercq W, Timmermans JP, Stroobants S, Augustyns K, De Meyer GRY, Van Der Veken P, Martinet W.

Biochem Pharmacol. 2017 Aug 15;138:150-162. doi: 10.1016/j.bcp.2017.06.119. Epub 2017 Jun 19.

PMID:
28642033
12.

Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography.

Rapic S, Vangestel C, Verhaeghe J, Van den Wyngaert T, Hinz R, Verhoye M, Pauwels P, Staelens S, Stroobants S.

Mol Imaging Biol. 2017 Oct;19(5):762-771. doi: 10.1007/s11307-017-1051-4.

PMID:
28194632
13.

Evaluation of [18F]CP18 as a Substrate-Based Apoptosis Imaging Agent for the Assessment of Early Treatment Response in Oncology.

Rapic S, Vangestel C, Elvas F, Verhaeghe J, den Wyngaert TV, Wyffels L, Pauwels P, Staelens S, Stroobants S.

Mol Imaging Biol. 2017 Aug;19(4):560-569. doi: 10.1007/s11307-016-1037-7.

PMID:
28050749
14.

Evaluation of [18 F]BR420 and [18 F]BR351 as radiotracers for MMP-9 imaging in colorectal cancer.

Vazquez N, Missault S, Vangestel C, Deleye S, Thomae D, Van der Veken P, Augustyns K, Staelens S, Dedeurwaerdere S, Wyffels L.

J Labelled Comp Radiopharm. 2017 Jan;60(1):69-79. doi: 10.1002/jlcr.3476. Epub 2016 Dec 21.

PMID:
28004430
15.

99mTc-Duramycin SPECT Imaging of Early Tumor Response to Targeted Therapy: A Comparison with 18F-FDG PET.

Elvas F, Boddaert J, Vangestel C, Pak K, Gray B, Kumar-Singh S, Staelens S, Stroobants S, Wyffels L.

J Nucl Med. 2017 Apr;58(4):665-670. doi: 10.2967/jnumed.116.182014. Epub 2016 Nov 22.

16.

Coadministration of a Gloriosa superba extract improves the in vivo antitumoural activity of gemcitabine in a murine pancreatic tumour model.

Capistrano I R, Vangestel C, Vanpachtenbeke H, Fransen E, Staelens S, Apers S, Pieters L.

Phytomedicine. 2016 Nov 15;23(12):1434-1440. doi: 10.1016/j.phymed.2016.07.012. Epub 2016 Aug 1.

PMID:
27765363
17.

Preclinical evaluation of [111 In]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activity.

Vangestel C, Thomae D, Van Soom J, Ides J, Wyffels L, Pauwels P, Stroobants S, Van der Veken P, Magdolen V, Joossens J, Augustyns K, Staelens S.

Contrast Media Mol Imaging. 2016 Nov;11(6):448-458. doi: 10.1002/cmmi.1706. Epub 2016 Aug 24.

PMID:
27558262
18.

Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.

Maggi A, Ruivo E, Fissers J, Vangestel C, Chatterjee S, Joossens J, Sobott F, Staelens S, Stroobants S, Van Der Veken P, Wyffels L, Augustyns K.

Org Biomol Chem. 2016 Aug 21;14(31):7544-51. doi: 10.1039/c6ob01411a. Epub 2016 Jul 19.

PMID:
27431745
19.

Evaluation of [18F]Fluorothymidine as a Biomarker for Early Therapy Response in a Mouse Model of Colorectal Cancer.

Rapic S, Vangestel C, Verhaeghe J, Thomae D, Pauwels P, Van den Wyngaert T, Staelens S, Stroobants S.

Mol Imaging Biol. 2017 Feb;19(1):109-119. doi: 10.1007/s11307-016-0974-5.

PMID:
27324368
20.

A longitudinal genetic survey identifies temporal shifts in the population structure of Dutch house sparrows.

Cousseau L, Husemann M, Foppen R, Vangestel C, Lens L.

Heredity (Edinb). 2016 Oct;117(4):259-67. doi: 10.1038/hdy.2016.38. Epub 2016 Jun 8.

21.

Efficacy Screening of Gloriosa Superba Extracts in a Murine Pancreatic Cancer Model Using (18)F-FDG PET/CT for Monitoring Treatment Response.

Capistrano R, Vangestel C, Wouters A, Dockx Y, Pauwels P, Stroobants S, Apers S, Lardon F, Pieters L, Staelens S.

Cancer Biother Radiopharm. 2016 Apr;31(3):99-109. doi: 10.1089/cbr.2015.1954.

PMID:
27093343
22.

Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.

Vandamme T, Beyens M, de Beeck KO, Dogan F, van Koetsveld PM, Pauwels P, Mortier G, Vangestel C, de Herder W, Van Camp G, Peeters M, Hofland LJ.

Br J Cancer. 2016 Mar 15;114(6):650-8. doi: 10.1038/bjc.2016.25.

23.

Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.

Elvas F, Vangestel C, Pak K, Vermeulen P, Gray B, Stroobants S, Staelens S, Wyffels L.

J Nucl Med. 2016 May;57(5):805-11. doi: 10.2967/jnumed.115.168344. Epub 2016 Feb 2.

24.

Baseline [(18)F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model.

De Bruycker S, Vangestel C, Van den Wyngaert T, Wyffels L, Wouters A, Pauwels P, Staelens S, Stroobants S.

Mol Imaging Biol. 2016 Aug;18(4):606-16. doi: 10.1007/s11307-015-0926-5.

PMID:
26728163
25.

Persistent inter- and intraspecific gene exchange within a parallel radiation of caterpillar hunter beetles (Calosoma sp.) from the Galápagos.

Hendrickx F, Backeljau T, Dekoninck W, Van Belleghem SM, Vandomme V, Vangestel C.

Mol Ecol. 2015 Jun;24(12):3107-21. doi: 10.1111/mec.13233.

PMID:
25958891
26.

Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis.

Elvas F, Vangestel C, Rapic S, Verhaeghe J, Gray B, Pak K, Stroobants S, Staelens S, Wyffels L.

Mol Imaging Biol. 2015 Dec;17(6):838-47. doi: 10.1007/s11307-015-0852-6.

27.

Post-fragmentation population structure in a cooperative breeding Afrotropical cloud forest bird: emergence of a source-sink population network.

Husemann M, Cousseau L, Callens T, Matthysen E, Vangestel C, Hallmann C, Lens L.

Mol Ecol. 2015 Mar;24(6):1172-87. doi: 10.1111/mec.13105. Epub 2015 Mar 6.

PMID:
25677704
28.

Synthesis and in vivo preclinical evaluation of an (18)F labeled uPA inhibitor as a potential PET imaging agent.

Ides J, Thomae D, Wyffels L, Vangestel C, Messagie J, Joossens J, Lardon F, Van der Veken P, Augustyns K, Stroobants S, Staelens S.

Nucl Med Biol. 2014 Jul;41(6):477-87. doi: 10.1016/j.nucmedbio.2014.03.019. Epub 2014 Mar 29.

PMID:
24768145
29.

Sex-biased dispersal at different geographical scales in a cooperative breeder from fragmented rainforest.

Vangestel C, Callens T, Vandomme V, Lens L.

PLoS One. 2013 Aug 9;8(8):e71624. doi: 10.1371/journal.pone.0071624. eCollection 2013.

30.

Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?

Mees G, Dierckx R, Vangestel C, Laukens D, Van Damme N, Van de Wiele C.

Mol Imaging. 2013 Jan-Feb;12(1):49-58.

PMID:
23348791
31.

Asymmetry of the ULNT1 elbow extension range-of-motion in a healthy population: consequences for clinical practice and research.

Van Hoof T, Vangestel C, Shacklock M, Kerckaert I, D'Herde K.

Phys Ther Sport. 2012 Aug;13(3):141-9. doi: 10.1016/j.ptsp.2011.09.003. Epub 2011 Oct 26.

PMID:
22814447
32.

Genetic diversity and population structure in contemporary house sparrow populations along an urbanization gradient.

Vangestel C, Mergeay J, Dawson DA, Callens T, Vandomme V, Lens L.

Heredity (Edinb). 2012 Sep;109(3):163-72. doi: 10.1038/hdy.2012.26. Epub 2012 May 16.

33.

Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model.

Vangestel C, Van de Wiele C, Mees G, Mertens K, Staelens S, Reutelingsperger C, Pauwels P, Van Damme N, Peeters M.

Mol Imaging. 2012 Apr;11(2):135-47.

PMID:
22469241
34.

Microsatellite resources for Passeridae species: a predicted microsatellite map of the house sparrow Passer domesticus.

Dawson DA, Horsburgh GJ, Krupa AP, Stewart IR, Skjelseth S, Jensen H, Ball AD, Spurgin LG, Mannarelli ME, Nakagawa S, Schroeder J, Vangestel C, Hinten GN, Burke T.

Mol Ecol Resour. 2012 May;12(3):501-23. doi: 10.1111/j.1755-0998.2012.03115.x. Epub 2012 Feb 9.

PMID:
22321340
35.

(99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab.

Vangestel C, Van de Wiele C, Van Damme N, Staelens S, Pauwels P, Reutelingsperger CP, Peeters M.

J Nucl Med. 2011 Nov;52(11):1786-94. doi: 10.2967/jnumed.111.092650.

36.

Spatial heterogeneity in genetic relatedness among house sparrows along an urban-rural gradient as revealed by individual-based analysis.

Vangestel C, Mergeay J, Dawson DA, Vandomme V, Lens L.

Mol Ecol. 2011 Nov;20(22):4643-53. doi: 10.1111/j.1365-294X.2011.05316.x. Epub 2011 Oct 18.

PMID:
22004175
37.

Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma.

Deron P, Vermeersch H, Mees G, Vangestel C, Pauwels P, Van de Wiele C.

Histol Histopathol. 2011 Sep;26(9):1165-72. doi: 10.14670/HH-26.1165.

PMID:
21751148
38.

Developmental stability covaries with genome-wide and single-locus heterozygosity in house sparrows.

Vangestel C, Mergeay J, Dawson DA, Vandomme V, Lens L.

PLoS One. 2011;6(7):e21569. doi: 10.1371/journal.pone.0021569. Epub 2011 Jul 1.

39.

In vivo imaging of apoptosis in oncology: an update.

Vangestel C, Peeters M, Mees G, Oltenfreiter R, Boersma HH, Elsinga PH, Reutelingsperger C, Van Damme N, De Spiegeleer B, Van de Wiele C.

Mol Imaging. 2011 Oct;10(5):340-58. doi: 10.2310/7290.2010.00058. Epub 2011 Apr 26. Review.

PMID:
21521554
40.

Metabolic correlates of tumour hypoxia in malignant canine mammary carcinoma.

Mees G, Vangestel C, Dierckx R, Loomans S, Van Damme N, Peremans K, De Rooster H, Van Goethem B, Pauwels P, Ducatelle R, Van de Wiele C.

Res Vet Sci. 2011 Dec;91(3):e125-8. doi: 10.1016/j.rvsc.2011.01.014. Epub 2011 Feb 12.

PMID:
21316722
41.

In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.

Vangestel C, Peeters M, Oltenfreiter R, D'Asseler Y, Staelens S, Van Steenkiste M, Philippé J, Kusters D, Reutelingsperger C, Van Damme N, Van de Wiele C.

Nucl Med Biol. 2010 Nov;37(8):965-75. doi: 10.1016/j.nucmedbio.2010.06.007. Epub 2010 Sep 20.

PMID:
21055628
42.

FDG uptake in primary squamous cell carcinoma of the head and neck. The relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis.

Deron P, Vangestel C, Goethals I, De Potter A, Peeters M, Vermeersch H, Van de Wiele C.

Nuklearmedizin. 2011;50(1):15-21. doi: 10.3413/nukmed-0324-10-06. Epub 2010 Nov 5.

PMID:
21052609
43.

Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.

Mees G, Vangestel C, Dierckx R, Pauwels P, Van Meerbeeck J, Van de Wiele C.

Cancer Biother Radiopharm. 2010 Apr;25(2):149-54. doi: 10.1089/cbr.2009.0658.

PMID:
20423227
44.

Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis.

Mees G, Fonteyne P, Ceelen W, Boterberg T, Pauwels P, Vangestel C, Van Damme N, Peeters M, Dierckx R, Van De Wiele C.

Cancer Biother Radiopharm. 2009 Oct;24(5):565-72. doi: 10.1089/cbr.2009.0621.

PMID:
19877886
45.

Forcing cancer cells to commit suicide.

Vangestel C, Van de Wiele C, Mees G, Peeters M.

Cancer Biother Radiopharm. 2009 Aug;24(4):395-407. doi: 10.1089/cbr.2008.0598. Review.

PMID:
19694574
46.

Molecular imaging of hypoxia with radiolabelled agents.

Mees G, Dierckx R, Vangestel C, Van de Wiele C.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1674-86. doi: 10.1007/s00259-009-1195-9. Epub 2009 Jun 30. Review.

47.

Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator.

Van Den Broeck T, Stevenaert F, Taveirne S, Debacker V, Vangestel C, Vandekerckhove B, Taghon T, Matthys P, Plum J, Held W, Dewerchin M, Yokoyama WM, Leclercq G.

Blood. 2008 Dec 15;112(13):5046-51. doi: 10.1182/blood-2008-06-164350. Epub 2008 Sep 10.

PMID:
18784372
48.

The impact of muscular variation on the neurodynamic test for the median nerve in a healthy population with Langer's axillary arch.

Van Hoof T, Vangestel C, Forward M, Verhaeghe B, Van Thilborgh L, Plasschaert F, De Muynck M, Vanderstraeten G, D'Herde K.

J Manipulative Physiol Ther. 2008 Jul-Aug;31(6):474-83. doi: 10.1016/j.jmpt.2008.06.007.

PMID:
18722204
49.

Identification and validation of housekeeping genes as internal control for gene expression in an intravenous LPS inflammation model in chickens.

De Boever S, Vangestel C, De Backer P, Croubels S, Sys SU.

Vet Immunol Immunopathol. 2008 Apr 15;122(3-4):312-7. doi: 10.1016/j.vetimm.2007.12.002. Epub 2008 Jan 3.

PMID:
18272235

Supplemental Content

Loading ...
Support Center